title: Vaccine Targeting of Subdominant CD8+ T Cell Epitopes Increases the Breadth of the T Cell Response upon Viral Challenge, but May Impair Immediate Virus Control.
abstract: As a result of the difficulties in making efficient vaccines against genetically unstable viruses such as HIV, it has been suggested that future vaccines should preferentially target subdominant epitopes, the idea being that this should allow a greater breadth of the induced T cell response and, hence, a greater efficiency in controlling escape variants. However, to our knowledge the evidence supporting this concept is limited at best. To improve upon this, we used the murine lymphocytic choriomeningitis virus model and adenoviral vectors to compare a vaccine expressing unmodified Ag to a vaccine expressing the same Ag without its immunodominant epitope. We found that removal of the dominant epitope allowed the induction of CD8(+) T cell responses targeting at least two otherwise subdominant epitopes. Importantly, the overall magnitude of the induced T cell responses was similar, allowing us to directly compare the efficiency of these vaccines. Doing this, we observed that mice vaccinated with the vaccine expressing unmodified Ag more efficiently controlled an acute viral challenge. In the course of a more chronic viral infection, mice vaccinated using the vaccine targeting subdominant epitopes caught up with the conventionally vaccinated mice, and analysis of the breadth of the CD8(+) T cell response revealed that this was notably greater in the former mice. However, under the conditions of our studies, we never saw any functional advantage of this. This may represent a limitation of our model, but clearly our findings underscore the importance of carefully weighing the pros and cons of changes in epitope targeting before any implementation.
authors.affiliation: Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark.
authors.forename: Maria A
authors.initials: MA
authors.lastname: Steffensen
authors.affiliation: Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark.
authors.forename: Louise H
authors.initials: LH
authors.lastname: Pedersen
authors.affiliation: Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark.
authors.forename: Marie L
authors.initials: ML
authors.lastname: Jahn
authors.affiliation: Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark.
authors.forename: Karen N
authors.initials: KN
authors.lastname: Nielsen
authors.affiliation: Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark.
authors.forename: Jan P
authors.identifier: http://orcid.org/0000-0002-4299-9479
authors.initials: JP
authors.lastname: Christensen
authors.affiliation: Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark athomsen@sund.ku.dk.
authors.forename: Allan R
authors.identifier: http://orcid.org/0000-0002-2392-9803
authors.initials: AR
authors.lastname: Thomsen
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology* / Q000821:virology; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D016056:Immunodominant Epitopes / Q000276:immunology; D008213:Lymphocyte Activation; D008217:Lymphocytic choriomeningitis virus / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009698:Nucleoproteins / Q000276:immunology; D014764:Viral Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage*
chemical_list: D016056:Immunodominant Epitopes; D009698:Nucleoproteins; D014764:Viral Proteins; D014765:Viral Vaccines